Vitamin B12 [EPC]

Vitamin B12 [EPC] was reported 317486 times

Drugs of the Vitamin B12 [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5514 0.8081
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 502 0.7676
2 SWOLLEN JOINT COUNT INCREASED 2242 0.7597
3 PEMPHIGUS 9048 0.7575
4 RHEUMATIC FEVER 3029 0.7313
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 1307 0.7057
6 DUODENAL ULCER PERFORATION 4906 0.7011
7 LUPUS VULGARIS 735 0.6825
8 RHEUMATOID FACTOR POSITIVE 3777 0.6757
9 C-REACTIVE PROTEIN 564 0.6513
10 HAND DEFORMITY 7623 0.6028
11 FACET JOINT SYNDROME 1765 0.6022
12 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1022 0.5407
13 HELICOBACTER INFECTION 4972 0.5087
14 DISLOCATION OF VERTEBRA 1020 0.4918
15 X-RAY ABNORMAL 769 0.4479
16 SYNOVITIS 7643 0.4362
17 MUSCLE INJURY 3407 0.4347
18 C-REACTIVE PROTEIN ABNORMAL 2662 0.4317
19 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2606 0.4203
20 RETINITIS 625 0.4051
21 GLOSSODYNIA 8609 0.3974
22 FOLLICULITIS 3915 0.3962
23 PERICARDITIS 6144 0.3841
24 PERIPHERAL VENOUS DISEASE 1417 0.3743
25 BLOOD PRESSURE SYSTOLIC ABNORMAL 857 0.3524
26 BLOOD PRESSURE DIASTOLIC ABNORMAL 862 0.3418
27 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 751 0.3300
28 SERONEGATIVE ARTHRITIS 334 0.3116
29 GRANULOMA SKIN 244 0.2998
30 BONE EROSION 1028 0.2992
31 SYSTEMIC LUPUS ERYTHEMATOSUS 10130 0.2960
32 WOUND 7569 0.2814
33 CONTRAINDICATED PRODUCT ADMINISTERED 7308 0.2501
34 ENTHESOPATHY 373 0.2433
35 JOINT DESTRUCTION 365 0.2386
36 DRUG TOLERANCE DECREASED 612 0.2252
37 BREAST CANCER STAGE III 1390 0.2248
38 GRIP STRENGTH DECREASED 1893 0.2237
39 PORPHYRIA ACUTE 288 0.2226
40 JOINT RANGE OF MOTION DECREASED 2804 0.2173
41 LIP DRY 1846 0.2153
42 RHEUMATOID NODULE 576 0.2107
43 ONYCHOMADESIS 817 0.2057
44 BURSITIS 2350 0.2015
45 HYPERCHOLESTEROLAEMIA 1852 0.2008
46 IRRITABLE BOWEL SYNDROME 4084 0.1975
47 LIVE BIRTH 1564 0.1949
48 WOUND INFECTION 2002 0.1917
49 BLOOD PARATHYROID HORMONE DECREASED 279 0.1904
50 FIBROMYALGIA 4316 0.1834
51 ONYCHOMYCOSIS 768 0.1810
52 ARTHROPATHY 9742 0.1794
53 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1863 0.1723
54 RHEUMATOID ARTHRITIS 18341 0.1671
55 TENOSYNOVITIS 434 0.1607
56 AUTOIMMUNE DISORDER 1460 0.1599
57 IMPAIRED HEALING 5034 0.1576
58 POLYCYSTIC OVARIES 240 0.1557
59 FINGER DEFORMITY 726 0.1534
60 BLEPHAROSPASM 884 0.1498
61 PSORIATIC ARTHROPATHY 5776 0.1492
62 INFUSION RELATED REACTION 9195 0.1437
63 FOOT DEFORMITY 1495 0.1381
64 LIVER INJURY 3188 0.1376
65 HIP ARTHROPLASTY 1975 0.1349
66 EXOSTOSIS 1191 0.1343
67 SCIATICA 2024 0.1321
68 OBESITY 1976 0.1275
69 NAIL DISORDER 1069 0.1275
70 PANNICULITIS 298 0.1270
71 PULMONARY FIBROSIS 2329 0.1259
72 THERAPEUTIC PRODUCT EFFECT DECREASED 5316 0.1245
73 LOWER RESPIRATORY TRACT INFECTION 5387 0.1234
74 BLOOD PRESSURE DIASTOLIC DECREASED 893 0.1231
75 DYSMORPHISM 287 0.1229
76 MATERNAL EXPOSURE TIMING UNSPECIFIED 441 0.1228
77 OSTEOARTHRITIS 5032 0.1218
78 TYPE 2 DIABETES MELLITUS 3985 0.1212
79 HEPATIC ENZYME INCREASED 7609 0.1154
80 INFUSION SITE REACTION 317 0.1154
81 DISCOMFORT 6696 0.1146
82 JOINT EFFUSION 772 0.1142
83 ALANINE AMINOTRANSFERASE ABNORMAL 230 0.1134
84 KNEE ARTHROPLASTY 2274 0.1131
85 SWELLING 9837 0.1086
86 BLOOD PRESSURE SYSTOLIC INCREASED 2070 0.1084
87 WALKING AID USER 697 0.1084
88 BLOOD PRESSURE DIASTOLIC INCREASED 485 0.1073
89 C-REACTIVE PROTEIN INCREASED 3792 0.1073
90 JOINT SWELLING 12499 0.1070
91 POLYARTHRITIS 534 0.1052
92 JOINT DISLOCATION 1045 0.1024
93 LUPUS-LIKE SYNDROME 890 0.1017
94 LARYNGITIS 1065 0.1011
95 MATERNAL EXPOSURE DURING PREGNANCY 8497 0.1000
96 NEPHROGENIC ANAEMIA 459 0.1000
97 BLISTER 5374 0.0989
98 SPONDYLITIS 346 0.0980
99 BLOOD CHOLESTEROL INCREASED 4408 0.0973
100 PUSTULAR PSORIASIS 326 0.0970
101 HYPERPARATHYROIDISM SECONDARY 235 0.0951
102 SYNOVIAL CYST 428 0.0942
103 DRUG INTOLERANCE 8609 0.0924
104 STOMATITIS 5397 0.0915
105 MUSCULOSKELETAL STIFFNESS 7738 0.0907
106 LOWER LIMB FRACTURE 1659 0.0902
107 PLEURITIC PAIN 245 0.0900
108 BLOOD PRESSURE FLUCTUATION 2083 0.0888
109 SICKLE CELL ANAEMIA WITH CRISIS 1355 0.0871
110 INFLAMMATION 4299 0.0867
111 BODY TEMPERATURE DECREASED 824 0.0846
112 PRESCRIBED OVERDOSE 1593 0.0846
113 GAIT INABILITY 2683 0.0843
114 GESTATIONAL DIABETES 376 0.0826
115 DRUG TOLERANCE 406 0.0822
116 BACK INJURY 859 0.0821
117 RED CELL DISTRIBUTION WIDTH INCREASED 327 0.0811
118 RHINITIS ALLERGIC 348 0.0809
119 SMALL FOR DATES BABY 393 0.0808
120 JOINT STIFFNESS 2047 0.0802
121 ABDOMINAL DISCOMFORT 12887 0.0796
122 SINUSITIS 7880 0.0788
123 CUSHINGOID 246 0.0784
124 MOBILITY DECREASED 5404 0.0779
125 NIGHT SWEATS 2428 0.0777
126 ARTHRITIS INFECTIVE 350 0.0776
127 ULCER HAEMORRHAGE 512 0.0775
128 VITAMIN B12 DEFICIENCY 298 0.0773
129 INTERVERTEBRAL DISC DEGENERATION 699 0.0768
130 SPINAL STENOSIS 296 0.0757
131 SPINAL OSTEOARTHRITIS 648 0.0754
132 BREATH SOUNDS ABNORMAL 359 0.0750
133 MUSCULOSKELETAL PAIN 3858 0.0746
134 TREATMENT FAILURE 5798 0.0732
135 PRESCRIBED UNDERDOSE 1392 0.0722
136 WHEEZING 4108 0.0719
137 CARPAL TUNNEL SYNDROME 975 0.0713
138 BASAL CELL CARCINOMA 1083 0.0713
139 ANTINUCLEAR ANTIBODY POSITIVE 227 0.0712
140 CONGENITAL ANOMALY 543 0.0712
141 HEPATIC CIRRHOSIS 1269 0.0702
142 SERUM FERRITIN INCREASED 358 0.0700
143 SPINAL FUSION SURGERY 271 0.0698
144 BRONCHIECTASIS 446 0.0698
145 TENDERNESS 710 0.0696
146 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3187 0.0696
147 NODULE 884 0.0695
148 NORMAL NEWBORN 365 0.0690
149 PREGNANCY 1367 0.0688
150 PRODUCT LABEL CONFUSION 383 0.0682
151 ALOPECIA 13015 0.0679
152 ARTHRITIS 5195 0.0678
153 IMMUNODEFICIENCY 958 0.0676
154 LIVER FUNCTION TEST INCREASED 1384 0.0674
155 COELIAC DISEASE 640 0.0672
156 CONTUSION 6266 0.0671
157 INTENTIONAL PRODUCT USE ISSUE 5695 0.0666
158 IRON DEFICIENCY 283 0.0664
159 EXPOSURE DURING PREGNANCY 4004 0.0662
160 EAR INFECTION 1701 0.0661
161 OEDEMA 3454 0.0657
162 ANAL FISSURE 339 0.0656
163 RASH VESICULAR 305 0.0654
164 WHEELCHAIR USER 284 0.0653
165 ILL-DEFINED DISORDER 3815 0.0645
166 VENTRICULAR SEPTAL DEFECT 362 0.0644
167 INFLAMMATORY MARKER INCREASED 301 0.0641
168 POSTOPERATIVE WOUND INFECTION 418 0.0639
169 SKIN NECROSIS 324 0.0637
170 POOR VENOUS ACCESS 637 0.0636
171 PERIPHERAL SWELLING 9436 0.0636
172 CARDIAC MURMUR 533 0.0626
173 ARTHRITIS BACTERIAL 246 0.0621
174 HAEMATOCRIT DECREASED 1212 0.0621
175 GENERAL PHYSICAL HEALTH DETERIORATION 6873 0.0620
176 BREAST CANCER STAGE II 508 0.0617
177 PRE-ECLAMPSIA 283 0.0614
178 INJECTION SITE PAPULE 267 0.0611
179 OSTEOPOROSIS 2447 0.0611
180 MENISCUS INJURY 363 0.0607
181 ATRIAL SEPTAL DEFECT 498 0.0607
182 NASOPHARYNGITIS 10809 0.0603
183 SPINAL COLUMN STENOSIS 285 0.0603
184 LUNG DISORDER 2858 0.0601
185 VITAMIN D DECREASED 494 0.0594
186 PREMATURE LABOUR 331 0.0591
187 SINUS CONGESTION 773 0.0586
188 VITAMIN D DEFICIENCY 550 0.0583
189 GASTROINTESTINAL DISORDER 4933 0.0583
190 EAR PAIN 1096 0.0579
191 HEART RATE DECREASED 1981 0.0576
192 SKIN ABRASION 259 0.0575
193 INJURY 3947 0.0570
194 ATELECTASIS 535 0.0566
195 HAEMOLYSIS 425 0.0566
196 APHTHOUS ULCER 417 0.0566
197 RHINITIS 442 0.0564
198 ROAD TRAFFIC ACCIDENT 2288 0.0562
199 MATERNAL EXPOSURE BEFORE PREGNANCY 369 0.0562
200 LOW BIRTH WEIGHT BABY 434 0.0561
201 SLEEP DISORDER 3786 0.0560
202 TASTE DISORDER 1071 0.0560
203 SLEEP APNOEA SYNDROME 1045 0.0560
204 ARTHRALGIA 22392 0.0559
205 UPPER RESPIRATORY TRACT INFECTION 2485 0.0555
206 FOOT OPERATION 262 0.0551
207 INFECTION 7537 0.0540
208 LOCALISED INFECTION 1269 0.0539
209 BLOOD IRON DECREASED 613 0.0539
210 BLOOD ALBUMIN DECREASED 413 0.0536
211 SENSORY LOSS 421 0.0534
212 UMBILICAL HERNIA 243 0.0533
213 TONGUE DISORDER 380 0.0533
214 POST PROCEDURAL INFECTION 415 0.0529
215 ROTATOR CUFF SYNDROME 666 0.0528
216 SKIN ULCER 1323 0.0527
217 HIATUS HERNIA 663 0.0524
218 RENAL CYST 405 0.0523
219 SQUAMOUS CELL CARCINOMA OF SKIN 302 0.0517
220 ANAL FISTULA 268 0.0517
221 NECK PAIN 2808 0.0516
222 LIVER DISORDER 2208 0.0513
223 PRE-EXISTING CONDITION IMPROVED 318 0.0513
224 THERAPY NON-RESPONDER 2196 0.0513
225 MOUTH ULCERATION 1043 0.0511
226 SCOLIOSIS 308 0.0511
227 ULCER 792 0.0510
228 GINGIVAL PAIN 391 0.0505
229 INCREASED TENDENCY TO BRUISE 455 0.0505
230 BRONCHITIS 3659 0.0504
231 HYPERCALCAEMIA 604 0.0504
232 HYPERSENSITIVITY 9061 0.0504
233 PULMONARY MASS 725 0.0503
234 HAEMOGLOBIN DECREASED 5047 0.0503
235 HUMERUS FRACTURE 237 0.0502
236 TOOTH INFECTION 643 0.0501
237 BLOOD TEST ABNORMAL 683 0.0501
238 SENSITIVITY TO WEATHER CHANGE 251 0.0498
239 TENDONITIS 755 0.0497
240 RESPIRATORY RATE INCREASED 429 0.0495
241 FOETAL GROWTH RESTRICTION 290 0.0495
242 OSTEOPENIA 736 0.0495
243 PHARYNGITIS 600 0.0494
244 RESPIRATORY TRACT INFECTION 1238 0.0493
245 TOOTH ABSCESS 493 0.0493
246 NERVE COMPRESSION 439 0.0491
247 IRON DEFICIENCY ANAEMIA 436 0.0491
248 OXYGEN SATURATION DECREASED 2644 0.0491
249 BLOOD MAGNESIUM DECREASED 411 0.0490
250 DRY MOUTH 3840 0.0490
251 GASTROOESOPHAGEAL REFLUX DISEASE 3792 0.0489
252 JOINT INJURY 1017 0.0489
253 CAESAREAN SECTION 563 0.0488
254 FREQUENT BOWEL MOVEMENTS 1266 0.0488
255 SKIN LACERATION 507 0.0487
256 GASTROENTERITIS VIRAL 849 0.0484
257 CELLULITIS 2380 0.0484
258 DIVERTICULUM 342 0.0481
259 HEPATITIS 1197 0.0481
260 BENIGN PROSTATIC HYPERPLASIA 242 0.0480
261 MATERNAL DRUGS AFFECTING FOETUS 367 0.0480
262 PANCYTOPENIA 2590 0.0479
263 STILLBIRTH 229 0.0479
264 IMMUNOSUPPRESSION 397 0.0478
265 CYST 578 0.0477
266 CYSTITIS 1486 0.0476
267 PELVIC FRACTURE 358 0.0474
268 HYPERKERATOSIS 255 0.0474
269 CONFUSIONAL STATE 7456 0.0473
270 FLANK PAIN 429 0.0472
271 RED BLOOD CELL COUNT DECREASED 1308 0.0469
272 SMALL INTESTINAL OBSTRUCTION 558 0.0469
273 DELIRIUM 1568 0.0468
274 RESPIRATORY TRACT CONGESTION 721 0.0467
275 EPILEPSY 1379 0.0467
276 ARTHROPOD BITE 333 0.0466
277 HYPOAESTHESIA 6796 0.0466
278 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 694 0.0465
279 LIGAMENT SPRAIN 444 0.0464
280 ADRENAL INSUFFICIENCY 530 0.0460
281 APLASTIC ANAEMIA 234 0.0459
282 SKIN INFECTION 497 0.0459
283 WEIGHT INCREASED 9779 0.0455
284 INGUINAL HERNIA 270 0.0455
285 HYPERTENSION 9375 0.0455
286 PLATELET COUNT INCREASED 575 0.0454
287 MYOSITIS 393 0.0453
288 HEPATIC STEATOSIS 816 0.0453
289 MUSCLE SPASTICITY 551 0.0452
290 TRICUSPID VALVE INCOMPETENCE 345 0.0452
291 DISABILITY 864 0.0451
292 MOTOR DYSFUNCTION 441 0.0449
293 POLYP 285 0.0448
294 PAIN 26735 0.0446
295 HAND FRACTURE 307 0.0445
296 ANKYLOSING SPONDYLITIS 558 0.0443
297 CONDITION AGGRAVATED 12907 0.0443
298 OEDEMA PERIPHERAL 5249 0.0439
299 FOOT FRACTURE 813 0.0439
300 FOETAL EXPOSURE DURING PREGNANCY 3471 0.0439
301 WEIGHT FLUCTUATION 440 0.0438
302 GASTROENTERITIS 619 0.0437
303 INTERVERTEBRAL DISC PROTRUSION 936 0.0437
304 PAIN IN EXTREMITY 12569 0.0437
305 MASS 595 0.0436
306 SPINAL DISORDER 402 0.0435
307 DYSPEPSIA 4103 0.0432
308 DRUG-INDUCED LIVER INJURY 1272 0.0432
309 HERPES ZOSTER 2412 0.0431
310 DRUG LEVEL BELOW THERAPEUTIC 228 0.0430
311 ORAL CANDIDIASIS 538 0.0429
312 DIVERTICULITIS 1148 0.0429
313 PRODUCT USE ISSUE 7653 0.0424
314 SEASONAL ALLERGY 571 0.0423
315 END STAGE RENAL DISEASE 765 0.0423
316 TOOTH FRACTURE 456 0.0423
317 MIGRAINE 3873 0.0423
318 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 673 0.0422
319 BACK DISORDER 670 0.0422
320 BONE DISORDER 759 0.0422
321 SPLENOMEGALY 478 0.0420
322 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2871 0.0419
323 SQUAMOUS CELL CARCINOMA 384 0.0419
324 PNEUMONIA 13088 0.0418
325 ARTERIOSCLEROSIS CORONARY ARTERY 267 0.0415
326 KIDNEY INFECTION 790 0.0414
327 GANGRENE 245 0.0414
328 NEUTROPENIC SEPSIS 289 0.0414
329 PRODUCTIVE COUGH 1873 0.0411
330 MITRAL VALVE INCOMPETENCE 450 0.0410
331 HEMIPLEGIA 332 0.0409
332 FISTULA 448 0.0408
333 ARTERIAL OCCLUSIVE DISEASE 314 0.0408
334 OROPHARYNGEAL PAIN 3662 0.0407
335 MUSCULAR WEAKNESS 4485 0.0406
336 WHITE BLOOD CELL COUNT INCREASED 1526 0.0406
337 LOCAL SWELLING 708 0.0405
338 PLEURISY 237 0.0405
339 RECTAL HAEMORRHAGE 1701 0.0404
340 URINARY TRACT INFECTION 6655 0.0403
341 TENDON DISORDER 255 0.0401
342 RHINORRHOEA 2496 0.0400
343 MUSCLE STRAIN 336 0.0400
344 TUBERCULOSIS 498 0.0398
345 FULL BLOOD COUNT ABNORMAL 407 0.0398
346 SPUTUM DISCOLOURED 365 0.0398
347 MUSCULOSKELETAL CHEST PAIN 597 0.0397
348 RIB FRACTURE 792 0.0397
349 MALIGNANT MELANOMA 519 0.0397
350 ORAL HERPES 745 0.0396
351 CARDIOMEGALY 480 0.0395
352 GROIN PAIN 339 0.0395
353 SPINAL COMPRESSION FRACTURE 327 0.0394
354 UVEITIS 516 0.0394
355 SPINAL PAIN 447 0.0394
356 BREAST MASS 257 0.0393
357 FATIGUE 29609 0.0393
358 DENTAL CARIES 424 0.0392
359 PHARYNGITIS STREPTOCOCCAL 413 0.0392
360 PREMATURE DELIVERY 612 0.0391
361 LACERATION 368 0.0391
362 MUSCULOSKELETAL DISCOMFORT 651 0.0390
363 VASCULITIS 440 0.0389
364 LIMB INJURY 1018 0.0388
365 UPPER-AIRWAY COUGH SYNDROME 306 0.0387
366 CATARACT 2221 0.0387
367 GAIT DISTURBANCE 7236 0.0387
368 PAROSMIA 283 0.0386
369 WRIST FRACTURE 450 0.0386
370 OSTEOMYELITIS 682 0.0386
371 OVARIAN CYST 380 0.0386
372 SINUS DISORDER 744 0.0386
373 TRANSFUSION 395 0.0385
374 GASTROINTESTINAL INFECTION 334 0.0385
375 BLOOD PRESSURE INCREASED 5743 0.0385
376 HEART RATE IRREGULAR 855 0.0385
377 UROSEPSIS 342 0.0384
378 DECUBITUS ULCER 304 0.0383
379 APPETITE DISORDER 236 0.0383
380 EMPHYSEMA 378 0.0383
381 PYREXIA 12889 0.0383
382 GASTRITIS 979 0.0382
383 HAEMOGLOBIN ABNORMAL 235 0.0382
384 RASH 15991 0.0382
385 TOOTHACHE 670 0.0381
386 DYSPNOEA EXERTIONAL 1380 0.0380
387 FEMUR FRACTURE 1151 0.0380
388 VIRAL INFECTION 1218 0.0379
389 NASAL CONGESTION 2143 0.0378
390 TOOTH DISORDER 822 0.0376
391 BODY HEIGHT DECREASED 398 0.0375
392 WEIGHT DECREASED 10150 0.0375
393 LARGE INTESTINE POLYP 252 0.0374
394 BLOOD POTASSIUM DECREASED 1096 0.0374
395 FAECES SOFT 260 0.0374
396 BLOOD URINE PRESENT 692 0.0373
397 ANAEMIA 6927 0.0373
398 ESCHERICHIA INFECTION 294 0.0372
399 ASTHMA 4011 0.0371
400 CHEST PAIN 6697 0.0370
401 CHOLELITHIASIS 1176 0.0370
402 FALL 11934 0.0370
403 HAEMORRHOIDS 698 0.0367
404 EYE INFECTION 399 0.0367
405 INFLUENZA 3960 0.0365
406 TENDON RUPTURE 441 0.0364
407 RENAL FAILURE CHRONIC 280 0.0364
408 NEPHROLITHIASIS 1610 0.0364
409 ANKLE FRACTURE 547 0.0362
410 GASTROINTESTINAL INFLAMMATION 273 0.0362
411 BODY TEMPERATURE INCREASED 722 0.0361
412 DRUG EXPOSURE DURING PREGNANCY 1229 0.0361
413 RASH PRURITIC 1882 0.0361
414 LOWER GASTROINTESTINAL HAEMORRHAGE 262 0.0361
415 GASTRIC ULCER 668 0.0360
416 UTERINE LEIOMYOMA 257 0.0359
417 CORONARY ARTERY OCCLUSION 484 0.0359
418 INJECTION SITE HAEMATOMA 517 0.0359
419 CROHN'S DISEASE 246 0.0358
420 ABSCESS 556 0.0358
421 FURUNCLE 276 0.0358
422 LUNG INFILTRATION 312 0.0358
423 CLOSTRIDIUM DIFFICILE INFECTION 747 0.0357
424 ABDOMINAL PAIN 8005 0.0355
425 PREMATURE BABY 1046 0.0354
426 GOUT 616 0.0353
427 AFFECT LABILITY 333 0.0353
428 AMNESIA 2245 0.0353
429 MALNUTRITION 377 0.0351
430 HYPERLIPIDAEMIA 410 0.0351
431 ABORTION SPONTANEOUS 1378 0.0351
432 ABDOMINAL PAIN UPPER 6940 0.0349
433 HAEMATOCHEZIA 1865 0.0349
434 HERNIA 646 0.0346
435 OESOPHAGITIS 368 0.0346
436 HEMIPARESIS 573 0.0345
437 HYPERAESTHESIA 279 0.0345
438 COORDINATION ABNORMAL 472 0.0344
439 DECREASED APPETITE 7697 0.0343
440 URINE OUTPUT DECREASED 293 0.0343
441 PSORIASIS 4348 0.0342
442 APHONIA 463 0.0342
443 BACK PAIN 7718 0.0341
444 DRUG HYPERSENSITIVITY 6464 0.0341
445 NEURALGIA 799 0.0340
446 HYPOTHYROIDISM 1050 0.0340
447 PYELONEPHRITIS 284 0.0340
448 BLOOD CALCIUM DECREASED 374 0.0340
449 CONCUSSION 255 0.0339
450 PNEUMONIA ASPIRATION 821 0.0339
451 HYPOKALAEMIA 1509 0.0339
452 UPPER LIMB FRACTURE 660 0.0339
453 PLEURAL EFFUSION 2000 0.0337
454 ORAL PAIN 738 0.0337
455 LIVER FUNCTION TEST ABNORMAL 962 0.0336
456 BLOOD UREA INCREASED 552 0.0335
457 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1697 0.0335
458 HYDRONEPHROSIS 243 0.0335
459 MUSCULOSKELETAL DISORDER 625 0.0335
460 ANAL INCONTINENCE 285 0.0334
461 BLOOD SODIUM DECREASED 609 0.0333
462 UPPER GASTROINTESTINAL HAEMORRHAGE 548 0.0333
463 INJECTION SITE PRURITUS 2139 0.0333
464 PARAESTHESIA 5113 0.0333
465 ASTHENIA 12105 0.0331
466 ARTERIOSCLEROSIS 305 0.0331
467 COUGH 8973 0.0331
468 BLOOD LACTATE DEHYDROGENASE INCREASED 516 0.0331
469 HYSTERECTOMY 276 0.0330
470 EATING DISORDER 687 0.0330
471 HEPATOMEGALY 317 0.0329
472 ACUTE RESPIRATORY FAILURE 611 0.0329
473 PHOTOPHOBIA 596 0.0329
474 ATRIAL FLUTTER 256 0.0329
475 GLAUCOMA 616 0.0328
476 RESPIRATORY DISORDER 957 0.0328
477 STAPHYLOCOCCAL INFECTION 1056 0.0327
478 IMMUNE SYSTEM DISORDER 418 0.0327
479 BLOOD CALCIUM INCREASED 278 0.0327
480 DYSSTASIA 933 0.0327
481 INJECTION SITE WARMTH 655 0.0327
482 INJECTION SITE EXTRAVASATION 400 0.0326
483 CLOSTRIDIUM DIFFICILE COLITIS 334 0.0325
484 LIMB DISCOMFORT 975 0.0324
485 NOCTURIA 381 0.0324
486 SECRETION DISCHARGE 382 0.0323
487 SNEEZING 700 0.0323
488 MUCOSAL INFLAMMATION 816 0.0323
489 INJECTION SITE REACTION 2140 0.0322
490 NEPHROPATHY 296 0.0322
491 ADVERSE REACTION 415 0.0321
492 INJECTION SITE IRRITATION 391 0.0321
493 LYMPHADENOPATHY 1102 0.0320
494 TUBULOINTERSTITIAL NEPHRITIS 580 0.0320
495 STRESS 2228 0.0320
496 SUPRAVENTRICULAR TACHYCARDIA 298 0.0320
497 MICTURITION URGENCY 351 0.0319
498 EAR DISCOMFORT 317 0.0319
499 SKIN LESION 838 0.0319
500 DRUG ERUPTION 543 0.0318
501 AORTIC ANEURYSM 238 0.0318
502 SEPTIC SHOCK 1330 0.0318
503 CHROMATURIA 698 0.0318
504 URTICARIA 5095 0.0317
505 PETECHIAE 318 0.0317
506 MEMORY IMPAIRMENT 4237 0.0316
507 COLITIS ULCERATIVE 1359 0.0316
508 BACTERIAL INFECTION 567 0.0316
509 LABORATORY TEST ABNORMAL 901 0.0315
510 CANDIDA INFECTION 504 0.0314
511 FULL BLOOD COUNT DECREASED 615 0.0313
512 GALLBLADDER DISORDER 546 0.0313
513 NEUTROPHIL COUNT INCREASED 314 0.0313
514 ALANINE AMINOTRANSFERASE INCREASED 1867 0.0312
515 PRODUCT ADMINISTRATION INTERRUPTED 231 0.0312
516 DRUG LEVEL DECREASED 311 0.0311
517 SCAB 340 0.0310
518 DYSPNOEA 16982 0.0309
519 DEHYDRATION 4005 0.0309
520 IMPAIRED WORK ABILITY 646 0.0309
521 PULMONARY HYPERTENSION 629 0.0308
522 HEADACHE 18738 0.0308
523 DIZZINESS POSTURAL 285 0.0308
524 FUNGAL INFECTION 997 0.0308
525 POST PROCEDURAL COMPLICATION 577 0.0307
526 SEPSIS 3326 0.0307
527 LYMPHOCYTE COUNT DECREASED 529 0.0307
528 MEDICATION ERROR 1648 0.0306
529 CONJUNCTIVITIS 542 0.0306
530 MUSCLE SPASMS 5464 0.0306
531 CHRONIC KIDNEY DISEASE 2293 0.0305
532 OBSTRUCTIVE AIRWAYS DISORDER 332 0.0305
533 ABDOMINAL DISTENSION 3055 0.0304
534 BLOOD COUNT ABNORMAL 459 0.0302
535 ATRIAL FIBRILLATION 2862 0.0302
536 SKIN CANCER 630 0.0301
537 DEPRESSION 6706 0.0300
538 DIARRHOEA HAEMORRHAGIC 274 0.0300
539 INFUSION SITE PAIN 371 0.0300
540 VOMITING 13623 0.0300
541 DIARRHOEA 18644 0.0300
542 ASPARTATE AMINOTRANSFERASE INCREASED 1550 0.0300
543 SKIN HAEMORRHAGE 411 0.0300
544 ELECTROCARDIOGRAM ABNORMAL 231 0.0299
545 IMPAIRED QUALITY OF LIFE 419 0.0299
546 HAEMOLYTIC ANAEMIA 261 0.0299
547 MULTIPLE ALLERGIES 227 0.0299
548 TRANSIENT ISCHAEMIC ATTACK 987 0.0299
549 BLOOD CREATININE INCREASED 1907 0.0299
550 PERICARDIAL EFFUSION 667 0.0299
551 DEFORMITY 278 0.0298
552 FEELING HOT 1779 0.0297
553 COVID-19 PNEUMONIA 344 0.0297
554 HYPOMAGNESAEMIA 399 0.0297
555 COLITIS 1076 0.0296
556 BLOOD POTASSIUM INCREASED 467 0.0296
557 ELECTROLYTE IMBALANCE 327 0.0296
558 KNEE OPERATION 275 0.0295
559 INSOMNIA 7657 0.0295
560 PNEUMONITIS 770 0.0295
561 ACUTE KIDNEY INJURY 4333 0.0294
562 RENAL TUBULAR NECROSIS 279 0.0293
563 DYSURIA 1048 0.0292
564 THERAPEUTIC RESPONSE DECREASED 1704 0.0292
565 HYPOPHAGIA 713 0.0291
566 INCONTINENCE 300 0.0291
567 PERIPHERAL COLDNESS 389 0.0290
568 DRY THROAT 286 0.0290
569 LUNG INFECTION 450 0.0289
570 HEPATIC CYTOLYSIS 329 0.0289
571 FLUID RETENTION 1431 0.0289
572 THROAT IRRITATION 1250 0.0289
573 MYELODYSPLASTIC SYNDROME 407 0.0289
574 RESTLESS LEGS SYNDROME 512 0.0288
575 PLATELET COUNT DECREASED 2976 0.0288
576 BALANCE DISORDER 2417 0.0287
577 INITIAL INSOMNIA 284 0.0287
578 DYSARTHRIA 1049 0.0286
579 MALAISE 12232 0.0286
580 INTERNATIONAL NORMALISED RATIO INCREASED 805 0.0284
581 INTESTINAL OBSTRUCTION 1026 0.0284
582 HYPOCALCAEMIA 519 0.0284
583 BACTERAEMIA 322 0.0284
584 INJECTION SITE BRUISING 2148 0.0284
585 INJECTION SITE NODULE 302 0.0283
586 INJECTION SITE DISCOLOURATION 339 0.0283
587 CHOLECYSTECTOMY 310 0.0282
588 FRACTURE 519 0.0282
589 HYPERSOMNIA 783 0.0281
590 APHASIA 830 0.0281
591 HEART RATE INCREASED 2695 0.0281
592 DERMATITIS ALLERGIC 336 0.0281
593 MACULAR DEGENERATION 323 0.0279
594 URINARY INCONTINENCE 806 0.0279
595 TOOTH EXTRACTION 339 0.0279
596 PRURITUS 10084 0.0279
597 PULMONARY CONGESTION 360 0.0279
598 SCRATCH 275 0.0278
599 INJECTION SITE ERYTHEMA 3322 0.0278
600 PNEUMONIA BACTERIAL 245 0.0278
601 HIP FRACTURE 866 0.0278
602 ANGINA PECTORIS 783 0.0278
603 NERVE INJURY 302 0.0278
604 SKIN DISCOLOURATION 1238 0.0277
605 DIZZINESS 13397 0.0277
606 MOVEMENT DISORDER 871 0.0277
607 EPISTAXIS 2021 0.0277
608 SPINAL FRACTURE 534 0.0277
609 DEEP VEIN THROMBOSIS 1758 0.0275
610 FEELING COLD 746 0.0275
611 NAUSEA 20987 0.0275
612 PALLOR 731 0.0275
613 PRESYNCOPE 643 0.0275
614 DECREASED IMMUNE RESPONSIVENESS 259 0.0274
615 HAEMATURIA 919 0.0274
616 RENAL DISORDER 1247 0.0274
617 POOR QUALITY SLEEP 568 0.0274
618 FAECES DISCOLOURED 576 0.0273
619 THROMBOCYTOPENIA 2955 0.0273
620 POLLAKIURIA 1100 0.0272
621 BLOOD PRESSURE ABNORMAL 522 0.0272
622 ATAXIA 316 0.0272
623 SPINAL OPERATION 314 0.0272
624 BLADDER DISORDER 264 0.0272
625 HYPOKINESIA 384 0.0272
626 CHILLS 3099 0.0271
627 RASH PAPULAR 592 0.0271
628 WHITE BLOOD CELL COUNT DECREASED 2855 0.0270
629 PHOTOSENSITIVITY REACTION 432 0.0270
630 HOSPICE CARE 258 0.0270
631 BURNING SENSATION 1841 0.0270
632 HYPERKALAEMIA 914 0.0270
633 DRY EYE 1238 0.0270
634 HEAD INJURY 826 0.0270
635 RENAL FAILURE ACUTE 1144 0.0269
636 PNEUMOCYSTIS JIROVECII PNEUMONIA 260 0.0269
637 ADVERSE DRUG REACTION 2321 0.0268
638 GINGIVAL BLEEDING 356 0.0268
639 ADVERSE EVENT 2402 0.0268
640 CORONARY ARTERY DISEASE 801 0.0267
641 HYPOTENSION 5202 0.0267
642 FACIAL PAIN 231 0.0267
643 THYROID DISORDER 399 0.0267
644 PULMONARY EMBOLISM 2480 0.0266
645 PULMONARY THROMBOSIS 283 0.0266
646 CHEST DISCOMFORT 2628 0.0266
647 HYPOXIA 904 0.0266
648 ASPIRATION 278 0.0265
649 CHOLECYSTITIS 304 0.0265
650 VITREOUS FLOATERS 248 0.0264
651 FLATULENCE 1441 0.0264
652 PAIN IN JAW 729 0.0264
653 SCAR 441 0.0264
654 LEUKOCYTOSIS 462 0.0264
655 TINNITUS 1177 0.0263
656 INJECTION SITE RASH 762 0.0262
657 INTESTINAL PERFORATION 285 0.0261
658 DYSPHONIA 1478 0.0260
659 LEUKOPENIA 1261 0.0260
660 GASTROINTESTINAL PAIN 275 0.0259
661 GENERALISED OEDEMA 309 0.0259
662 INJECTION SITE PAIN 7548 0.0259
663 GASTROINTESTINAL HAEMORRHAGE 2120 0.0258
664 INTERSTITIAL LUNG DISEASE 1204 0.0257
665 HYPONATRAEMIA 1406 0.0257
666 SKIN DISORDER 827 0.0257
667 BLOOD ALKALINE PHOSPHATASE INCREASED 624 0.0257
668 HEAD DISCOMFORT 436 0.0257
669 EYE INFLAMMATION 233 0.0256
670 RASH MACULAR 864 0.0256
671 PULMONARY OEDEMA 1118 0.0256
672 MUSCLE ATROPHY 310 0.0256
673 INJECTION SITE URTICARIA 596 0.0256
674 ORTHOSTATIC HYPOTENSION 433 0.0255
675 DEVICE RELATED INFECTION 382 0.0254
676 SWOLLEN TONGUE 773 0.0254
677 BEDRIDDEN 324 0.0254
678 MENTAL STATUS CHANGES 685 0.0253
679 INJECTION SITE HAEMORRHAGE 1935 0.0252
680 INJECTION SITE INDURATION 319 0.0252
681 ABASIA 623 0.0252
682 INJECTION SITE SWELLING 1825 0.0251
683 CARDIAC FAILURE CONGESTIVE 1986 0.0249
684 DYSPHAGIA 2287 0.0249
685 ACTIVITIES OF DAILY LIVING IMPAIRED 494 0.0249
686 INTERNAL HAEMORRHAGE 278 0.0249
687 URINARY RETENTION 805 0.0249
688 SINUS TACHYCARDIA 343 0.0248
689 CONSTIPATION 5151 0.0247
690 NEUROPATHY PERIPHERAL 2255 0.0247
691 COAGULOPATHY 398 0.0246
692 BONE MARROW FAILURE 492 0.0246
693 EYE DISORDER 780 0.0246
694 PROCEDURAL PAIN 657 0.0245
695 VENTRICULAR EXTRASYSTOLES 249 0.0245
696 HAEMATOMA 623 0.0245
697 THROMBOSIS 1922 0.0244
698 THERAPY CESSATION 1212 0.0244
699 BLOOD PRESSURE DECREASED 1575 0.0244
700 OFF LABEL USE 20406 0.0244
701 WRONG TECHNIQUE IN DRUG USAGE PROCESS 888 0.0244
702 RENAL FAILURE 3188 0.0244
703 INFLUENZA LIKE ILLNESS 1961 0.0243
704 SWELLING FACE 1531 0.0243
705 HAEMATEMESIS 601 0.0243
706 FLUID OVERLOAD 352 0.0242
707 ANXIETY 6693 0.0241
708 QUALITY OF LIFE DECREASED 315 0.0241
709 VERTIGO 1422 0.0240
710 LYMPHOMA 362 0.0240
711 BLOOD BILIRUBIN INCREASED 632 0.0239
712 FEBRILE NEUTROPENIA 1535 0.0239
713 ACUTE MYOCARDIAL INFARCTION 693 0.0239
714 SARS-COV-2 TEST POSITIVE 314 0.0239
715 BREAST PAIN 248 0.0238
716 DERMATITIS CONTACT 262 0.0238
717 LETHARGY 1330 0.0238
718 MELAENA 512 0.0238
719 RETCHING 490 0.0238
720 GASTRIC DISORDER 816 0.0237
721 PARAESTHESIA ORAL 331 0.0237
722 TEMPERATURE INTOLERANCE 233 0.0236
723 PNEUMOTHORAX 363 0.0236
724 ABDOMINAL PAIN LOWER 580 0.0235
725 RENAL PAIN 242 0.0235
726 MYOCARDIAL ISCHAEMIA 264 0.0235
727 TACHYCARDIA 2029 0.0235
728 HAEMOPTYSIS 639 0.0235
729 MUSCLE TIGHTNESS 367 0.0233
730 BLOOD TRIGLYCERIDES INCREASED 403 0.0233
731 PALPITATIONS 2643 0.0233
732 INTENTIONAL DOSE OMISSION 593 0.0233
733 BONE PAIN 1322 0.0233
734 ANOREXIA 300 0.0233
735 HYPOAESTHESIA ORAL 339 0.0232
736 GLOMERULAR FILTRATION RATE DECREASED 270 0.0231
737 IMPAIRED GASTRIC EMPTYING 265 0.0231
738 FEEDING DISORDER 438 0.0231
739 ERYTHEMA 4606 0.0231
740 TRANSAMINASES INCREASED 498 0.0231
741 DRUG EFFECT DECREASED 1239 0.0230
742 PANCREATITIS 1180 0.0230
743 DRUG INEFFECTIVE 29381 0.0230
744 EYE HAEMORRHAGE 299 0.0229
745 NEUTROPHIL COUNT DECREASED 895 0.0229
746 DRUG EFFECT INCOMPLETE 830 0.0228
747 ASCITES 653 0.0228
748 SURGERY 1269 0.0228
749 SYNCOPE 2220 0.0228
750 MIDDLE INSOMNIA 410 0.0227
751 HYPERTENSIVE CRISIS 246 0.0227
752 RASH ERYTHEMATOUS 1012 0.0226
753 VISUAL IMPAIRMENT 2680 0.0226
754 PRURITUS GENERALISED 489 0.0226
755 RASH MACULO-PAPULAR 485 0.0226
756 DEAFNESS 570 0.0224
757 DECREASED ACTIVITY 233 0.0224
758 SKIN FISSURES 397 0.0224
759 RASH GENERALISED 580 0.0224
760 SENSORY DISTURBANCE 351 0.0223
761 INSURANCE ISSUE 305 0.0223
762 FLUSHING 2213 0.0222
763 HOT FLUSH 1630 0.0222
764 RESPIRATORY FAILURE 1571 0.0221
765 MULTIPLE FRACTURES 359 0.0221
766 COVID-19 3805 0.0220
767 DERMATITIS 434 0.0219
768 DIPLOPIA 548 0.0218
769 DIABETES MELLITUS INADEQUATE CONTROL 373 0.0217
770 DEPRESSED MOOD 1109 0.0217
771 MYALGIA 3586 0.0217
772 FEELING JITTERY 403 0.0216
773 SUBDURAL HAEMATOMA 302 0.0216
774 DIABETES MELLITUS 1614 0.0216
775 DEMENTIA 580 0.0216
776 MULTI-ORGAN FAILURE 372 0.0215
777 ORAL DISCOMFORT 290 0.0214
778 JAUNDICE 564 0.0214
779 ERUCTATION 382 0.0214
780 LACRIMATION INCREASED 613 0.0213
781 LOSS OF CONSCIOUSNESS 2660 0.0213
782 SOMNOLENCE 4134 0.0212
783 RENAL IMPAIRMENT 1711 0.0211
784 THIRST 363 0.0210
785 EOSINOPHILIA 355 0.0210
786 PRODUCT DOSE OMISSION 1371 0.0210
787 COGNITIVE DISORDER 944 0.0209
788 NEUTROPENIA 2734 0.0208
789 LYMPHOPENIA 284 0.0208
790 RESPIRATORY DISTRESS 558 0.0208
791 HYPERTHYROIDISM 290 0.0207
792 PELVIC PAIN 364 0.0206
793 COLD SWEAT 353 0.0206
794 TREMOR 3321 0.0205
795 CARDIOMYOPATHY 296 0.0205
796 THERAPEUTIC RESPONSE SHORTENED 607 0.0205
797 ECONOMIC PROBLEM 312 0.0205
798 UNEVALUABLE EVENT 1505 0.0204
799 ILLNESS 1920 0.0203
800 TOXIC EPIDERMAL NECROLYSIS 297 0.0203
801 AGEUSIA 492 0.0202
802 GENERALISED TONIC-CLONIC SEIZURE 319 0.0202
803 DISORIENTATION 783 0.0202
804 HYPERHIDROSIS 2534 0.0202
805 ILEUS 238 0.0201
806 PRODUCT USE IN UNAPPROVED INDICATION 4685 0.0200
807 ENCEPHALOPATHY 474 0.0200
808 SPEECH DISORDER 1022 0.0200
809 POLYNEUROPATHY 230 0.0200
810 EJECTION FRACTION DECREASED 300 0.0198
811 AGRANULOCYTOSIS 352 0.0197
812 EYE PAIN 1049 0.0197
813 FEELING ABNORMAL 4611 0.0197
814 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3305 0.0196
815 DYSGEUSIA 1432 0.0196
816 PERITONITIS 394 0.0196
817 THROAT TIGHTNESS 513 0.0196
818 TREATMENT NONCOMPLIANCE 1024 0.0195
819 BLINDNESS UNILATERAL 266 0.0194
820 PANCREATITIS ACUTE 420 0.0194
821 HALLUCINATION, VISUAL 394 0.0194
822 CARDIAC DISORDER 1776 0.0194
823 LIP SWELLING 625 0.0194
824 HALLUCINATION 1404 0.0194
825 UNDERDOSE 1369 0.0193
826 VAGINAL HAEMORRHAGE 804 0.0193
827 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1361 0.0191
828 DEVICE MALFUNCTION 1207 0.0190
829 APATHY 269 0.0190
830 NERVOUSNESS 975 0.0190
831 DELUSION 285 0.0190
832 UNRESPONSIVE TO STIMULI 473 0.0190
833 DISTURBANCE IN ATTENTION 993 0.0188
834 ECZEMA 875 0.0188
835 SKIN REACTION 255 0.0187
836 NIGHTMARE 630 0.0186
837 CEREBROVASCULAR ACCIDENT 3080 0.0186
838 DRUG DOSE OMISSION 3071 0.0186
839 CENTRAL NERVOUS SYSTEM LESION 251 0.0185
840 THERAPEUTIC RESPONSE UNEXPECTED 812 0.0185
841 ACUTE RESPIRATORY DISTRESS SYNDROME 317 0.0184
842 COLON CANCER 267 0.0184
843 LUNG NEOPLASM MALIGNANT 738 0.0183
844 CARDIOGENIC SHOCK 252 0.0183
845 EYE SWELLING 653 0.0182
846 SKIN EXFOLIATION 1452 0.0182
847 SEIZURE 2005 0.0181
848 INCREASED APPETITE 319 0.0180
849 MENTAL IMPAIRMENT 427 0.0180
850 METABOLIC ACIDOSIS 549 0.0180
851 VISION BLURRED 2382 0.0180
852 PHARYNGEAL OEDEMA 275 0.0179
853 DRUG INTERACTION 2759 0.0179
854 HEPATOTOXICITY 382 0.0179
855 MENORRHAGIA 349 0.0177
856 ISCHAEMIC STROKE 309 0.0177
857 PULMONARY ARTERIAL HYPERTENSION 253 0.0177
858 GAMMA-GLUTAMYLTRANSFERASE INCREASED 382 0.0177
859 PANIC ATTACK 626 0.0176
860 HAEMORRHAGE 1787 0.0176
861 CYANOSIS 270 0.0176
862 ARRHYTHMIA 814 0.0175
863 RENAL INJURY 517 0.0175
864 CIRCULATORY COLLAPSE 292 0.0175
865 EMOTIONAL DISORDER 531 0.0175
866 MOOD SWINGS 541 0.0174
867 HYPOGLYCAEMIA 820 0.0174
868 DIALYSIS 241 0.0174
869 DYSKINESIA 679 0.0172
870 PAIN OF SKIN 452 0.0172
871 BRADYCARDIA 890 0.0172
872 ANAPHYLACTIC REACTION 911 0.0172
873 CRYING 610 0.0171
874 CARDIO-RESPIRATORY ARREST 700 0.0170
875 THERAPY INTERRUPTED 1096 0.0170
876 CONVULSION 970 0.0169
877 CARDIAC FAILURE 1314 0.0168
878 CHOLESTASIS 307 0.0166
879 ACUTE MYELOID LEUKAEMIA 249 0.0165
880 HYPOACUSIS 687 0.0165
881 PRODUCT PRESCRIBING ERROR 373 0.0165
882 VENTRICULAR TACHYCARDIA 265 0.0164
883 PLASMA CELL MYELOMA 626 0.0164
884 MUSCLE TWITCHING 370 0.0164
885 HOSPITALISATION 2395 0.0163
886 ANHEDONIA 425 0.0163
887 INJECTION SITE MASS 582 0.0163
888 OCULAR HYPERAEMIA 731 0.0163
889 CHOKING 306 0.0163
890 DRUG LEVEL INCREASED 261 0.0162
891 HYPERGLYCAEMIA 570 0.0161
892 RESTLESSNESS 574 0.0161
893 INCORRECT DOSE ADMINISTERED 3456 0.0160
894 PROTEINURIA 288 0.0158
895 HALLUCINATION, AUDITORY 245 0.0158
896 METASTASES TO BONE 248 0.0157
897 PRODUCT SUBSTITUTION ISSUE 869 0.0155
898 MYOCARDIAL INFARCTION 2678 0.0155
899 DEVICE ISSUE 1288 0.0154
900 DRY SKIN 1941 0.0154
901 METASTASES TO LIVER 261 0.0153
902 BLOOD CREATINE PHOSPHOKINASE INCREASED 441 0.0152
903 BONE DENSITY DECREASED 471 0.0152
904 PRODUCT DOSE OMISSION ISSUE 4031 0.0151
905 THINKING ABNORMAL 276 0.0151
906 CEREBRAL HAEMORRHAGE 523 0.0150
907 INTENTIONAL PRODUCT MISUSE 1267 0.0150
908 MOOD ALTERED 395 0.0150
909 FEAR 397 0.0150
910 VISUAL ACUITY REDUCED 490 0.0149
911 MULTIPLE ORGAN DYSFUNCTION SYNDROME 397 0.0149
912 CEREBRAL INFARCTION 355 0.0149
913 COMA 689 0.0148
914 ABNORMAL DREAMS 404 0.0148
915 EYE PRURITUS 460 0.0147
916 OSTEONECROSIS OF JAW 357 0.0146
917 FACE OEDEMA 242 0.0146
918 ACNE 1086 0.0146
919 PRODUCT DOSE OMISSION IN ERROR 362 0.0146
920 PRODUCT AVAILABILITY ISSUE 312 0.0145
921 ACCIDENTAL OVERDOSE 513 0.0144
922 BLINDNESS 560 0.0142
923 CARDIOVASCULAR DISORDER 355 0.0141
924 CARDIAC ARREST 1142 0.0141
925 DISEASE PROGRESSION 1607 0.0141
926 PARANOIA 238 0.0141
927 AGITATION 1008 0.0140
928 NEEDLE ISSUE 384 0.0140
929 ANGER 461 0.0139
930 MULTIPLE SCLEROSIS 653 0.0139
931 MENTAL DISORDER 586 0.0138
932 CYTOKINE RELEASE SYNDROME 241 0.0136
933 NERVOUS SYSTEM DISORDER 413 0.0135
934 SUICIDAL IDEATION 1202 0.0135
935 BLOOD GLUCOSE DECREASED 630 0.0134
936 PRODUCT ADMINISTRATION ERROR 256 0.0133
937 TOOTH LOSS 272 0.0133
938 MALIGNANT NEOPLASM PROGRESSION 1298 0.0132
939 IRRITABILITY 776 0.0132
940 NEOPLASM MALIGNANT 855 0.0132
941 STEVENS-JOHNSON SYNDROME 287 0.0132
942 PSYCHOTIC DISORDER 377 0.0131
943 MULTIPLE SCLEROSIS RELAPSE 887 0.0131
944 PRODUCT QUALITY ISSUE 1716 0.0130
945 BLOOD GLUCOSE INCREASED 2338 0.0127
946 ERECTILE DYSFUNCTION 317 0.0126
947 OSTEONECROSIS 407 0.0125
948 RHABDOMYOLYSIS 500 0.0124
949 HEPATIC FAILURE 359 0.0122
950 AGGRESSION 599 0.0122
951 EYE IRRITATION 644 0.0122
952 ELECTROCARDIOGRAM QT PROLONGED 422 0.0121
953 DEPRESSED LEVEL OF CONSCIOUSNESS 460 0.0120
954 ABNORMAL BEHAVIOUR 468 0.0120
955 DISEASE RECURRENCE 553 0.0119
956 DEVICE DISLOCATION 493 0.0117
957 INCORRECT PRODUCT ADMINISTRATION DURATION 229 0.0116
958 SHOCK 243 0.0110
959 SKIN IRRITATION 492 0.0110
960 NEOPLASM PROGRESSION 377 0.0109
961 ANGIOEDEMA 460 0.0107
962 HEPATIC FUNCTION ABNORMAL 383 0.0107
963 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 589 0.0107
964 INCORRECT DRUG ADMINISTRATION DURATION 290 0.0103
965 SEDATION 260 0.0103
966 ANAPHYLACTIC SHOCK 252 0.0102
967 LACTIC ACIDOSIS 307 0.0100
968 DRUG ADMINISTRATION ERROR 305 0.0099
969 MENSTRUATION IRREGULAR 251 0.0097
970 RESPIRATORY ARREST 261 0.0096
971 GLYCOSYLATED HAEMOGLOBIN INCREASED 231 0.0095
972 SKIN BURNING SENSATION 653 0.0095
973 DEATH 7901 0.0094
974 PHARMACEUTICAL PRODUCT COMPLAINT 245 0.0094
975 TOXICITY TO VARIOUS AGENTS 1425 0.0088
976 WITHDRAWAL SYNDROME 361 0.0088
977 BREAST CANCER 806 0.0087
978 OVERDOSE 1811 0.0086
979 MYELOSUPPRESSION 246 0.0079
980 EMOTIONAL DISTRESS 932 0.0078
981 EXPIRED PRODUCT ADMINISTERED 239 0.0074
982 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1415 0.0072
983 PROSTATE CANCER 509 0.0064
984 DEVICE LEAKAGE 255 0.0064
985 SUICIDE ATTEMPT 369 0.0062
986 DERMATITIS ATOPIC 268 0.0059
987 ACCIDENTAL EXPOSURE TO PRODUCT 518 0.0055
988 NO ADVERSE EVENT 787 0.0046
989 PRODUCT STORAGE ERROR 384 0.0046
990 DRUG WITHDRAWAL SYNDROME 345 0.0040
991 INTENTIONAL OVERDOSE 233 0.0038
992 DEVICE EXPULSION 229 0.0036
993 COMPLETED SUICIDE 255 0.0031
994 DRUG ABUSE 239 0.0029
995 DRUG DEPENDENCE 308 0.0019